1. Home
  2. ORIO vs TXMD Comparison

ORIO vs TXMD Comparison

Compare ORIO & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ORIO

Orion Digital Corp. Common Shares

N/A

Current Price

$0.98

Market Cap

22.3M

Sector

N/A

ML Signal

N/A

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$2.00

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORIO
TXMD
Founded
N/A
2008
Country
Canada
United States
Employees
188
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.3M
24.3M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
ORIO
TXMD
Price
$0.98
$2.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
39.4K
20.2K
Earning Date
03-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
73.68
EPS
N/A
0.01
Revenue
N/A
$1,761,000.00
Revenue This Year
$74.52
N/A
Revenue Next Year
$5.07
N/A
P/E Ratio
$4.93
$201.50
Revenue Growth
N/A
35.25
52 Week Low
$0.90
$0.98
52 Week High
$1.40
$2.95

Technical Indicators

Market Signals
Indicator
ORIO
TXMD
Relative Strength Index (RSI) 37.85 46.25
Support Level N/A $1.93
Resistance Level $1.11 $2.05
Average True Range (ATR) 0.05 0.10
MACD -0.01 -0.00
Stochastic Oscillator 8.33 37.16

Price Performance

Historical Comparison
ORIO
TXMD

About ORIO Orion Digital Corp. Common Shares

Orion Digital Corp is a financial technology company operating digital platforms across wealth and payments, supported by a consumer lending business in Canada. The Company's Wealth platform, Intelligent Investing, provides long-term investment solutions to the Canadian market. It also operates a consumer lending business in Canada. Its Payments business is conducted through its wholly owned subsidiary, which provides issuer processing, program management, and regulated payment orchestration services across Europe. The Company operates in Canada and Europe, with Canada generating the majority of its revenue.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: